HRTS vs THNR
Tema ETF Trust Tema Heart & Health ETF against Amplify Weight Loss Drug & Treatment ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
28%
11 shared positions
Fee gap
16 bp
THNR is cheaper
1-year return gap
11.6 pts
HRTS is ahead
Larger fund
HRTS
$54M
Side by side
| HRTS | THNR | |
|---|---|---|
| Fund | Tema ETF Trust Tema Heart & Health ETF | Amplify Weight Loss Drug & Treatment ETF |
| Issuer | Tema | Amplify |
| Category | Health Care | Global |
| Expense ratio | 0.75% | 0.59% |
| Assets | $54M | $5.6M |
| Average daily dollar volume | $83K | $18K |
| Listed | Nov 20, 2023 | May 20, 2024 |
| FrenzyCap score | 19 | 22 |
| 1-month return | +0.1% | −4.6% |
| 3-month return | −0.5% | −4.4% |
| Year to date | +2.6% | −2.8% |
| 1-year return | +11.2% | −0.4% |
| 30-day volatility | 14.2% | 19.2% |
| Worst drawdown, 1 year | −11.0% | −13.1% |
| Trailing 12-month yield | 1.31% | 1.69% |
| Holdings | 45 | 21 |
| Top 10 weight | 49.1% | 60.2% |
| Look-through P/E | 143.3 | — |
| Holdings vs fair value | +2.1% | −1.7% |
| Holdings above 200-day average | 72% | 59% |
| Net flow, latest 3 reported months | −$698K thru May 2026 | $0 thru Jun 2026 |
| 30-day implied volatility | 16.5% | — |
| Holdings as of | as of May 31, 2026SEC filing | as of Jun 30, 2026SEC filing |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
30% of HRTS · 57% of THNR
Sector mix of the stock holdings
| Sector | HRTS | THNR | Gap |
|---|---|---|---|
| Health Care | 70.5% | 66.5% | +3.9% |
| Technology | 6.6% | 0.0% | +6.6% |
More: full overlap table · HRTS holdings · THNR holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.